These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22863288)

  • 1. Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses.
    Takuva S; Westreich D; Menezes CN; McNamara L; Sanne I; Page-Shipp L; Maskew M
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1358-64. PubMed ID: 22863288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
    BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.
    Pepper DJ; Marais S; Wilkinson RJ; Bhaijee F; De Azevedo V; Meintjes G
    PLoS One; 2011 May; 6(5):e19484. PubMed ID: 21589868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).
    Kaplan R; Caldwell J; Middelkoop K; Bekker LG; Wood R
    J Acquir Immune Defic Syndr; 2014 Aug; 66(5):487-94. PubMed ID: 24820105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children.
    Soeters HM; Sawry S; Moultrie H; Rie AV
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):136-44. PubMed ID: 25072611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
    Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
    J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa.
    Lawn SD; Campbell L; Kaplan R; Boulle A; Cornell M; Kerschberger B; Morrow C; Little F; Egger M; Wood R;
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):136-40. PubMed ID: 21436714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.
    Pepper DJ; Marais S; Wilkinson RJ; Bhaijee F; Maartens G; McIlleron H; De Azevedo V; Cox H; McDermid C; Sokhela S; Patel J; Meintjes G
    BMC Infect Dis; 2010 Mar; 10():83. PubMed ID: 20353569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.
    Kaplan R; Hermans S; Caldwell J; Jennings K; Bekker LG; Wood R
    BMC Infect Dis; 2018 Jul; 18(1):356. PubMed ID: 30064368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection.
    Patel MR; Nana M; Yotebieng M; Tabala M; Behets F; Van Rie A
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):694-9. PubMed ID: 24903941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.
    Kerschberger B; Hilderbrand K; Boulle AM; Coetzee D; Goemaere E; De Azevedo V; Van Cutsem G
    PLoS One; 2012; 7(10):e46988. PubMed ID: 23071690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
    Yende-Zuma N; Naidoo K
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.
    Manosuthi W; Tantanathip P; Chimsuntorn S; Eampokarap B; Thongyen S; Nilkamhang S; Sungkanuparph S
    Int J Infect Dis; 2010 Nov; 14(11):e1013-7. PubMed ID: 20880733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.
    Daniels JF; Khogali M; Mohr E; Cox V; Moyo S; Edginton M; Hinderaker SG; Meintjes G; Hughes J; De Azevedo V; van Cutsem G; Cox HS
    PLoS One; 2015; 10(11):e0142873. PubMed ID: 26555134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.
    Okulicz JF; Le TD; Agan BK; Camargo JF; Landrum ML; Wright E; Dolan MJ; Ganesan A; Ferguson TM; Smith DM; Richman DD; Little SJ; Clark RA; He W; Ahuja SK
    JAMA Intern Med; 2015 Jan; 175(1):88-99. PubMed ID: 25419650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines.
    Choun K; Pe R; Thai S; Lorent N; Lynen L; van Griensven J
    Bull World Health Organ; 2013 Mar; 91(3):195-206. PubMed ID: 23476092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.
    Arenas-Pinto A; Thompson J; Musoro G; Musana H; Lugemwa A; Kambugu A; Mweemba A; Atwongyeire D; Thomason MJ; Walker AS; Paton NI;
    J Neurovirol; 2016 Feb; 22(1):104-13. PubMed ID: 26323809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment.
    Yotebieng M; Van Rie A; Moultrie H; Cole SR; Adimora A; Behets F; Meyers T
    AIDS; 2010 Jun; 24(9):1341-9. PubMed ID: 20559039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.